Correlation Between Vertex Pharmaceuticals and Incyte
Can any of the company-specific risk be diversified away by investing in both Vertex Pharmaceuticals and Incyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vertex Pharmaceuticals and Incyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vertex Pharmaceuticals and Incyte, you can compare the effects of market volatilities on Vertex Pharmaceuticals and Incyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vertex Pharmaceuticals with a short position of Incyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vertex Pharmaceuticals and Incyte.
Diversification Opportunities for Vertex Pharmaceuticals and Incyte
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Vertex and Incyte is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Vertex Pharmaceuticals and Incyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Incyte and Vertex Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vertex Pharmaceuticals are associated (or correlated) with Incyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Incyte has no effect on the direction of Vertex Pharmaceuticals i.e., Vertex Pharmaceuticals and Incyte go up and down completely randomly.
Pair Corralation between Vertex Pharmaceuticals and Incyte
Given the investment horizon of 90 days Vertex Pharmaceuticals is expected to generate 1.33 times more return on investment than Incyte. However, Vertex Pharmaceuticals is 1.33 times more volatile than Incyte. It trades about -0.13 of its potential returns per unit of risk. Incyte is currently generating about -0.69 per unit of risk. If you would invest 41,603 in Vertex Pharmaceuticals on January 25, 2024 and sell it today you would lose (1,112) from holding Vertex Pharmaceuticals or give up 2.67% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vertex Pharmaceuticals vs. Incyte
Performance |
| Timeline |
| Vertex Pharmaceuticals |
| Incyte |
Vertex Pharmaceuticals and Incyte Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vertex Pharmaceuticals and Incyte
The main advantage of trading using opposite Vertex Pharmaceuticals and Incyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vertex Pharmaceuticals position performs unexpectedly, Incyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Incyte will offset losses from the drop in Incyte's long position.| Vertex Pharmaceuticals vs. Biomarin Pharmaceutical | Vertex Pharmaceuticals vs. Sarepta Therapeutics | Vertex Pharmaceuticals vs. Alnylam Pharmaceuticals | Vertex Pharmaceuticals vs. Intellia Therapeutics |
| Incyte vs. Adaptimmune Therapeutics Plc | Incyte vs. Mereo BioPharma Group | Incyte vs. PDS Biotechnology Corp | Incyte vs. Leap Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |